CytoMed Therapeutics (GDTC) Short-term Investments (2022 - 2023)

CytoMed Therapeutics has disclosed Short-term Investments across 2 years of filings, most recently posting $5.2 million for Q4 2023.

• In Q4 2023, Short-term Investments rose 11066.29% year-over-year to $5.2 million; the TTM figure through Dec 2023 stood at $5.2 million (up 11066.29% YoY), while the FY2023 annual figure was $5.2 million, up 11050.17% from the prior year.
• Short-term Investments came in at $5.2 million for Q4 2023 at CytoMed Therapeutics, up from $46582.9 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $5.2 million in Q4 2023 to a low of $46582.9 in Q4 2022.